Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Brain : a Journal of Neurology
|
October 21, 2017
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Maria A Rocca, Maria Pia Sormani, Marco Rovaris, et al.
CNS Drugs
|
December 11, 2021
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study
Serena Palmeri, Marta Ponzano, Federico Ivaldi, et al.
Journal of Autoimmunity
|
May 10, 2016
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis
Alice Laroni, Eric Armentani, Nicole Kerlero de Rosbo, et al.
Patient Preference and Adherence
|
January 15, 2021
Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
Elisabeth G Celius, Heidi Thompson, Maija Pontaga, et al.
Genes and Immunity
|
June 12, 2025
Butyrate enhances CD56<sup>bright</sup> NK cell-driven killing of activated T cells and modulates NK cell chromatin accessibility
Federico Carlini, Margherita Squillario, Valentina Casella, et al.
BMC Neurology
|
June 3, 2014
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection
Alice Laroni, Ilaria Gandoglia, Claudio Solaro, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 23, 2021
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
Maria Cellerino, Giacomo Boffa, Caterina Lapucci, et al.
European Journal of Immunology
|
May 16, 2025
The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES<sup>+</sup> Tr1-Like Cells
Nadia Pulvirenti, Chiara Vasco, Camilla Righetti, et al.
Journal of the Neurological Sciences
|
September 15, 2019
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod
Emilio Vanoli, Nicola Montano, Giuseppe De Angelis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 6, 2020
Tailoring B cell depletion therapy in MS according to memory B cell monitoring
Giovanni Novi, Francesca Bovis, Sabrina Fabbri, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Brain : a Journal of Neurology
|
October 21, 2017
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Maria A Rocca, Maria Pia Sormani, Marco Rovaris, et al.
CNS Drugs
|
December 11, 2021
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study
Serena Palmeri, Marta Ponzano, Federico Ivaldi, et al.
Journal of Autoimmunity
|
May 10, 2016
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis
Alice Laroni, Eric Armentani, Nicole Kerlero de Rosbo, et al.
Patient Preference and Adherence
|
January 15, 2021
Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
Elisabeth G Celius, Heidi Thompson, Maija Pontaga, et al.
Genes and Immunity
|
June 12, 2025
Butyrate enhances CD56<sup>bright</sup> NK cell-driven killing of activated T cells and modulates NK cell chromatin accessibility
Federico Carlini, Margherita Squillario, Valentina Casella, et al.
BMC Neurology
|
June 3, 2014
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection
Alice Laroni, Ilaria Gandoglia, Claudio Solaro, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 23, 2021
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
Maria Cellerino, Giacomo Boffa, Caterina Lapucci, et al.
European Journal of Immunology
|
May 16, 2025
The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES<sup>+</sup> Tr1-Like Cells
Nadia Pulvirenti, Chiara Vasco, Camilla Righetti, et al.
Journal of the Neurological Sciences
|
September 15, 2019
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod
Emilio Vanoli, Nicola Montano, Giuseppe De Angelis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 6, 2020
Tailoring B cell depletion therapy in MS according to memory B cell monitoring
Giovanni Novi, Francesca Bovis, Sabrina Fabbri, et al.
Page
of 8